Sage Therapeutics, Inc. (SAGE) Financial Statements (2024 and earlier)

Company Profile

Business Address 215 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,272,4941,742,2962,099,5491,008,393922,776518,848
Cash and cash equivalents162,700294,2331,661,082126,705190,943306,235
Short-term investments1,109,7941,448,063438,467881,688731,833212,613
Receivables13,66018,506    
Other undisclosed current assets50,82639,84122,82126,70021,9196,227
Total current assets:1,336,9801,800,6432,122,3701,035,093944,695525,075
Noncurrent Assets
Operating lease, right-of-use asset10,53216,10925,06433,771
Property, plant and equipment2,8983,0166,7559,1265,6434,013
Restricted cash and investments1,2691,2691,7162,3672,367849
Other noncurrent assets4,7704,2513,3413,793  
Total noncurrent assets:19,46924,64536,87649,0578,0104,862
TOTAL ASSETS:1,356,4491,825,2882,159,2461,084,150952,705529,937
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities91,61677,72558,542101,88486,03051,951
Accounts payable18,95010,4503,69115,26634,0369,350
Accrued liabilities72,66667,27554,85186,61851,99442,601
Debt    10,244  
Other undisclosed current liabilities7,6437,4688,662   
Total current liabilities:99,25985,19367,204112,12886,03051,951
Noncurrent Liabilities
Long-term debt and lease obligation:  10,96419,43826,848  
Liabilities, other than long-term debt 4,5911002705193,7042,511
Other liabilities 1001002705193,7042,511
Operating lease, liability 4,49110,96419,43826,848
Total noncurrent liabilities: 4,59111,06419,70827,3673,7042,511
Total liabilities:103,85096,25786,912139,49589,73454,462
Equity
Equity, attributable to parent1,252,5991,729,0312,072,334944,655862,971475,475
Common stock666555
Treasury stock, value(400)(400)(400)(400)(211)(113)
Additional paid in capital3,291,3693,227,4713,109,8072,587,3221,827,0211,066,059
Accumulated other comprehensive income (loss)(10,206)(2,660)4151,295(515)(29)
Accumulated deficit(2,028,170)(1,495,386)(1,037,494)(1,643,567)(963,329)(590,447)
Total equity:1,252,5991,729,0312,072,334944,655862,971475,475
TOTAL LIABILITIES AND EQUITY:1,356,4491,825,2882,159,2461,084,150952,705529,937

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues7,6866,3081,114,2006,86890,273 
Gross profit:7,6866,3081,114,2006,86890,273 
Operating expenses(554,675)(467,217)(517,974)(714,992)(483,511)(273,155)
Other undisclosed operating income      
Operating income (loss):(546,989)(460,909)596,226(708,124)(393,238)(273,155)
Nonoperating income (expense)(5,838)(12,912)(798)7,0489,914(64)
Investment income, nonoperating(5,853)(13,046)(1,048)6,9669,892 
Other nonoperating income (expense)151342508222(64)
Other undisclosed income from continuing operations before equity method investments, income taxes   10,645   
Income (loss) from continuing operations before equity method investments, income taxes:(552,827)(473,821)606,073(701,076)(383,324)(273,219)
Other undisclosed income from continuing operations before income taxes20,04315,929    
Income (loss) from continuing operations:(532,784)(457,892)606,073(701,076)(383,324)(273,219)
Income (loss) before gain (loss) on sale of properties:(457,892)606,073(701,076)(383,324)(273,219)
Other undisclosed net income (loss)   20,83810,442 
Net income (loss):(532,784)(457,892)606,073(680,238)(372,882)(273,219)
Other undisclosed net income attributable to parent     3,099
Net income (loss) available to common stockholders, diluted:(532,784)(457,892)606,073(680,238)(372,882)(270,120)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(532,784)(457,892)606,073(680,238)(372,882)(273,219)
Other comprehensive income (loss)(7,546)(3,075)(880)1,810(486)73
Comprehensive income (loss):(540,330)(460,967)605,193(678,428)(373,368)(273,146)
Other undisclosed comprehensive income, net of tax, attributable to parent     3,099
Comprehensive income (loss), net of tax, attributable to parent:(540,330)(460,967)605,193(678,428)(373,368)(270,047)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: